Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER-2 Gene Amplification × MM-111 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Stomach Neoplasms 1 Neoplasm Metastasis 1 HER-2 Gene Amplification 1 Esophageal Neoplasms 1

Interventions

Trastuzumab 1 Paclitaxel 1 MM-111 1 Lapatinib 1 Docetaxel 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01304784 2015-12-16

A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer

Merrimack Pharmaceuticals

Phase 1 Completed

HER-2 Gene Amplification

Data powered by HemOnc (CC BY 4.0) Colophon ⚡